Atlas Trials

A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD

Clinical trial NCT03994224 · TERMINATED

Trial details

NCT number
NCT03994224
Sponsor
Chinese University of Hong Kong
Status
TERMINATED
Study type
OBSERVATIONAL
Crohn DiseasePerianal Crohn Disease
Start date
2019-02-18
Primary completion
2022-08-29
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.